Treatment for selective reduction of regional fat deposits
Patent 4588724 Issued on May 13, 1986. Estimated Expiration Date: 
January 11, 2005. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
January 11, 2005. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.InventorsApplicationNo. 06/690651 filed on 01/11/1985US Classes:514/250, At least three rings in the polycyclo ring system514/280, Pentacyclo ring system having the six-membered hetero ring as one of the cyclos514/321, Plural hetero atoms in the polycyclo ring system514/400, At imidazole ring carbon514/909OBESITYExaminersPrimary: Robinson, Douglas W.Attorney, Agent or FirmInternational ClassesA61K 47/00 (20060101)A61K 31/135 (20060101) A61K 31/41 (20060101) A61K 31/52 (20060101) A61K 31/48 (20060101) A61K 31/519 (20060101) A61K 31/475 (20060101) AbstractA treatment for accelerating regional weight reduction in humans, wherein an active ingredient encouraging elimination of fatty deposits, preferably a beta adrenergic stimulator or an alpha-2 adrenergic inhibitor, is selectively delivered to a regional fat deposit prior to commencing or during a general weight control program, whereby body weight is preferentially reduced in the selected area. The beta adrenergic stimulator, preferably isoproterenol or forskolin, or the alpha-2 adrenergic inhibitor, preferably yohimbine, or combinations thereof may be delivered by any means accomplishing specific delivery to the selected area, including injection, implantation, and topical application to the skin as in an ointment or creme.Other References
| |
